- Subscription price of €8.50 set at discount to TERP of 6.9%
- Rights issue proceeds to fund investment pipeline of current growth strategy
- Kempen & Co acted as Joint Bookrunner in this transaction
At Kempen.com, we use cookies to improve the quality of our website and service.
The investment services and investment institutions mentioned on the website may not be available in your jurisdiction or to anyone other than professional investors. More information about the countries where these investment institutions are registered and the persons to whom they may be offered can be found on the website.
Click here to view our Privacy Policy.
